X hits on this document

Word document

Adverse Outcomes in Blood and Blood Component Therapy - page 18 / 19

83 views

0 shares

0 downloads

0 comments

18 / 19

31.

Van Buren NL, Stroncek DF, Clay ME, McCullough J, Dalmasso AP. Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion 1990;30(1):42-45

32.

Dubois M, Lotze MT, Diamond WJ, Kim YD, Flye MW, Macnamara TE. Pulmonary shunting during leukoagglutinin-induced noncardiac pulmonary edema. JAMA 1980;244(19):2186-2189

33.

Bruneau C, Perez P, Chassaigne M, Allouch P, Audurier A, Gulian C, Janus G, Boulard G, De Micco P, Salmi LR, Noel L Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donations Transfusion 2001; 41: 74-81

34.

de Korte D, Marcelis JH, Soeterboek AM. Determination of the degree of bacterialcontamination of whole-blood collections using anautomated microbe-detection system Transfusion 2001; 41: 815-818

35.

Perez P, Salmi LR, Folléa G, Schmit JL, de Barbeyrac B, Sudre P, Salamon R. Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study Transfusion 2001 41: 862-872

36.

Gibb AP, Martin KM, Davidson GA, Walker B, Murphy WG. Modeling the growth of Yersinia enterocolitica in donated blood Transfusion 1994 34: 304-310.

37.

Brecher ME, Means N, Jere CS, Heath D, Rothenberg S, Stutzman LC. Evaluation of an automated culture systemfor detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms Transfusion 2001:41:477-482.

38.

Brecher ME, Wong ECC, Chen SE, Vampola C, Rocco RM. Antibiotic-labeled probes and microvolume fluorimetry for the rapid detection of bacterial contamination in platelet components: a preliminary report Transfusion 2000;40: 411-413

39.

Roth VR, Arduino MJ, Nobiletti J, Holt SC, Carson LA, Wolf CF, Lenes BA, Allison PM, Jarvis WR. Transfusion-related sepsis due to Serratia liquefaciens in the United States. Transfusion 2000 ;40(8):931-935

40.

Hennig H, Luhm J, Hartwig D, Klüter H, Kirchner H. A novel RT-PCR for reliable and rapid HCV RNA screening of blood donations Transfusion 2001 41: 1100-1106.

41.

Herrera GA, Lackritz EM, Janssen RS, Raimondi VP, Dodd RY, Aberle-Grasse J, Petersen LR. Serologic test for syphilis as a surrogate marker for human immunodeficiency virus infection among United States blood donors Transfusion 1997;37: 836-840

42.

Ragni MV, Triulzi DJ, Bass D, Duerstein S. Transfusion and cytomegalovirus-associated AIDS-defining disease in hemophiliacs. Hemophilia Malignancy Study Transfusion 1996 36: 681-684.

43.

Inaba S, Okochi K, Sato H, Fukada K, Kinukawa N, Nakata H, Kinjyo K, Fujii F, Maeda Y. Efficacy of donor screening for HTLV-I and the natural history of transfusion-transmitted infection Transfusion 1999;39:1104-1110

44.

Biagini P, Gallian P, Touinssi M, Cantaloube JF, Zapitelli JP, de Lamballerie X, de Micco P. High prevalence of TT virus infection in French blood donors revealed by the use of three PCR systems Transfusion 2000;40:590-595

45.

Nordbø SA., Krokstad S, Winge P, Skjeldestad FE, Dalen AB. Prevalence of GB Virus C (Also Called Hepatitis G Virus) Markers in Norwegian Blood Donors. J. Clin. Microbiol. 2000; 38: 2584-2590

Document info
Document views83
Page views99
Page last viewedSat Dec 03 00:38:05 UTC 2016
Pages19
Paragraphs174
Words12213

Comments